Prescribers and pharmaceutical representatives: Why are we still meeting?

Journal of General Internal Medicine

Volumn 24, Issue 7, 2009, Pages 795-801

  Fischer, Melissa A ^a,b   Keough, Mary Ellen ^a,b,c,d   Baril, Joann L ^a,b,c,d   Saccoccio, Laura ^a,b,c,d   Mazor, Kathleen M ^a,b,c,d   Ladd, Elissa ^e   Worley, Ann Von ^f   Gurwitz, Jerry H ^a,b,c,d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Fallon Community Health Plan   (United States)

^d Fallon Clinic   (United States)

^e MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

^f LOVELACE CLINIC FOUNDATION   (United States)

Author keywords

Pharmaceutical marketing; Policy; Prescriber behavior; Training

Indexed keywords

ADULT; AGED; ARTICLE; DRUG INDUSTRY; DRUG MARKETING; FEMALE; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NURSE PRACTITIONER; PATIENT CARE; PHARMACIST; PHYSICIAN; PHYSICIAN ASSISTANT; PRESCRIPTION; SOCIAL INTERACTION; CLINICAL PRACTICE; COGNITION; CONFLICT OF INTEREST; ETHICS; MARKETING; MEDICAL ETHICS; MIDDLE AGED; QUALITATIVE RESEARCH;

ADULT; AGED; COGNITIVE DISSONANCE; CONFLICT OF INTEREST; DRUG INDUSTRY; ETHICS, MEDICAL; FEMALE; FOCUS GROUPS; HUMANS; MALE; MARKETING; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUALITATIVE RESEARCH;

EID: 67649422133     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-0989-6     Document Type: Article

References (61)

1. MY Peay ER Peay 1988 The role of commercial sources in the adoption of a new drug Soc Sci Med 26 12 1183 9
2. J Avorn M Chen R Hartley 1982 Scientific versus commercial sources of influence on the prescribing behavior of physicians Am J Med 73 1 4 8 (Pubitemid 12048270)
3. A Wazana 2000 Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283 3 373 80
4. JW Banks 3rd AG Mainous 3rd 1992 Attitudes of medical school faculty towards gifts from the pharmaceutical industry Acad Med 67 9 610 2
5. M Steinman M Shlipak S McPhee 2001 Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions Am J Med 110 7 551 7
6. T Brennan D Rothman L Blank 2006 Health industry practices that create conflicts of interest: a policy proposal for academic medical centers JAMA 294 4 429 33
7. H Minnigan CD Chisholm 2006 Conflict of interest in the physician interface with the biomedical industry E Med Clin N Amer 4 3 671 85
8. K Campo O De Staebel E Gijsbrechts W van Waterschoot 2005 Physician's decision process for drug prescription and the impact of pharmaceutical marketing mix instruments Health Mark Quar 2 4 73 107 (Pubitemid 43945575)
9. M Vainiomaki O Helve L Vuorenkoski 2004 A national survey on the effect of pharmaceutical promotion on medical students Med Teach 6 7 630 4
10. RF Adair LR Holmgren 2005 Do drug samples influence resident prescribing behavior? A randomized trial Am J Med 118 8 881 4
11. NJ Crigger 2005 Pharmaceutical promotions and conflict of interest in nurse practitioner's decision: making the undiscovered country J Am Acad NP 17 6 207 12
12. S Nissen K Wolski 2007 Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 24 2457 71
13. C Rosen 2007 The rosiglitazone story - lessons from an FDA advisory committee meeting N Engl J Med 357 9 844 6
14. Abramson J. Overdoed America: The Broken Promise of American Medicine. New York: Harper Collins; 2004.
15. Angell M. The Truth About the Drug Companies: How They Deceive Us and What To Do About It. New York: Random House, Inc.; 2004.
16. Avorn J. Powerful medicines. The Benefits, Risks and Costs of Prescription Drugs. New York: Alfred a Knopf/Random House, Inc.; 2004.
17. Is Your Doctor Tied to Drug Makers? Editorial New York Times. July 2, 2007 www.nytimes.com/2007/07/02/opinion/02mon2.html. Accessed April 7, 2009.
18. Lee C. Drugmakers, Doctors Get Cozier. Washington Post. April 29, 2007; page A03. www.washingtonpost.com/wp-dyn/content/article/2007/04/28/ AR2007042800896.html. Accessed April 7, 2009.
19. Dubner S. What Don't We Know About the Pharmaceutical Industry? A Freakonomics Quorum. New York Times. January 24, 2008. http://freakonomics. blogs.nytimes.com/2008/01/24/what-dont-we-know-about-the-pharmaceutical- industry-a-freakonomics-quorum/. Accessed April 7, 2009.
20. Murphy S. Drug Sale Said Tied to Favors at Lahey. The Boston Globe. November 9, 2002. Page A1.
21. MA Steinman LA Bero M Chresn CS Landefeld 2006 Narrative review. The promotion of gabapentin: an analysis of internal industry documents Ann Int Med 145 4 284 93
22. EG Campbell RL Gruen J Mountford LG Miller PD Cleary D Blumenthal 2007 A national survey of physician-industry relationships N Engl J Med 356 17 1742 50
23. S Chimonas TA Brannan DJ Rothman 2007 Physicians and drug representatives: exploring the dynamics of the relationship J Gen Intern Med 22 2 184 90
24. FS Sierles AC Brodkey LM Cleary 2005 Medical students' exposure to and attitudes about drug company interactions: a national survey JAMA 294 9 1034 42
25. WP McKinney DL Schiedermayer N Luria 1990 Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives JAMA 264 13 1693 7
26. M Bellin S Mccarthy L Drevlow C Pierach 2004 Medical student' exposure to pharmaceutical industry marketing: a survey at one U.S. medical school Acad Med 74 11 1041 5
27. AS Brett W Burr J Moloo 2003 Are gifts from pharmaceutical companies ethically problematic? A survey of physicians Arch Intern Med 163 18 2213 8
28. D Zipkin M Steinman 2005 Interactions between PRs and doctors in training. A thematic review J Gen Intern Med 20 8 777 86
29. Jutel A, Menkes D. Soft targets: nurses and the pharmaceutical industry. PloS Med. 5(2)e5 doi: 10.1371/journal.pmed.0050005.
30. Revised external funds policy - update from SGIM President Barbara Turner. 2006 Jan 26. http://www.sgim.org/index.cfm?section = site&pageId = 367. Accessed April 7, 2009.
31. B Kuehn 2005 Pharmaceutical industry funding for residencies sparks controversy JAMA 293 1572 80
32. Academic Medical Centers Increasingly Ban Gifts from Pharmaceutical Industry. Medical News Today. http://www.medicalnewstoday.com/articles/62478. php. Accessed April 7, 2009.
33. AMA Opinion of the Council on Ethical and Judicial Affairs, E-8.061. http://www.mcg.edu/SOM/medicine/documents/AMAGuidelinesforIndustry.pdf. Accessed April 7, 2009.
34. American Society of Internal Medicine American College of Physicians 2002 Position Paper. Pharmacist scope of practice Ann Intern Med 136 79 85
35. Stanford School of Medicine. News Release: New Stanford Medical Center Policy Limits Drug Company Access and Gifts. 9/12/06. http://med.stanford.edu/ news-releases/2006/september/coi.html. Accessed April 7, 2009.
36. Kowalczyk L. UMass Policy Limits Doctor, Drug Maker Ties. The Boston Globe. December 24, 2007. www.boston.com/business/healthcare/articles/2007/12/ 24/umass-policy-limits-doctor-drug-maker-ties/. Accessed April 7, 2009.
37. Yale University Policy on Conflict of Interest and Conflict of Commitment. www.yale.edu/provost/html/conflict.pdf. Accessed April 7, 2009.
38. Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. http://www.accme.org/dir-docs/doc-upload/68b2902a-fb73- 44d1-8725-80a1504e520c-uploaddocument.pdf. Accessed April 7, 2009.
39. Industry Funding of Medical Education: Report of an AAMC Task Force, June 2008. https://services.aamc.org/publications/showfile.cfm?file = version114.pdf&prd-id = 232&prv-id = 281&pdf-id = 114. Accessed April 7, 2009.
40. B Hagen EM Pijl-Zieber K Souveny A Lacroix 2008 Let's do lunch? The ethics of accepting gifts from the pharmaceutical industry Can Nurse 104 4 30 5
41. CL Stokamer 2003 Pharmaceutical gift giving: analysis of an ethical dilemma J Nurs Admin 33 1 48 51 (Pubitemid 36091512)
42. H Prosser T Walley 2003 Understanding why GPs see pharmaceutical representatives: a qualitative interview study Br J Gen Pract 53 489 305 11
43. J Wofford C Ohl 2005 Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes BMC Med Ed 5 1 5
44. Cialdini R. Influence: Science and Practice 4th ed. Needham Heights, MA: Allyn & Bacon; 2001.
45. S Agrawal I Saluja J Kaczorowski 2004 A prospective before-and-after trial of an educational intervention about pharmaceutical marketing Acad Med 9 11 1046 50
46. G Anastasio JM Little Jr 1996 Pharmaceutical marketing: implications for medical residency training Pharmacother 16 1 103 7
47. DC Vinson B McCandless MC Hosokawa 1993 Medical students' attitudes toward pharmaceutical marketing: possibilities for change Fam Med 25 1 31 3
48. CP Nelson DA Bloom 2001 Sales and science: changing patterns of pharmaceutical and medical device advertising in peer reviewed urology publications J Urol 166 6 2317 20
49. J Greene 2007 Pharmaceutical marketing research and the prescribing physician Ann Int Med 146 742 8
50. MS Monaghan KA Galt PD Turner 2003 Student understanding of the relationship between the health professions and the pharmaceutical industry TLM 15 1 14 20 (Pubitemid 37026183)
51. K Larson J Levy MG Rome TD Matte LD Silver TR Frieden 2006 Public health detailing: a strategy to improve the delivery of clinical preventive services in New York City Pub Health Rep 121 3 228 34
52. SB Soumerai J Avorn 1990 Principles of educational outreach ('academic detailing') to improve clinical decision making JAMA 63 4 549 56
53. Federation of State Medical Boards (FSMB) Research and Education Foundation Online Prescriber Education Network (OPEN) Web-based portal: Attorney General Consumer and Prescriber Education Grant Program modules available at http://www.fsmb.org/re/open/modules.html. Accessed April 7, 2009.
54. Consumer Reports Best Buy Drugs. http://www.consumerreports.org/health/ best-buy-drugs/index.htm. Accessed April 7, 2009.
55. SL Cutrona S Woolhandler KE Lasser DH Bor D McCormick DU Himmelstein 2008 Characteristics of recipients of free prescription drug samples: a nationally representative analysis Am J Public Health 98 2 284 9
56. LD Spiller WW Wymer Jr 2001 Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians Hlth Mark Quart 19 1 91 106
57. R Levy 1994 The role and value of pharmaceutical marketing Arch Fam Med 3 4 327 32
58. A Fugh-Berman S Ahari 2007 Following the script: how drug reps make friends and influence doctors PLoS Med 4 4 0621 5
59. VF Eckardt 2000 Complimentary journeys to the World Congress of Gastroenterology - an inquiry of potential sponsors and beneficiaries Zeitschr Gastro 38 1 7 11 (Pubitemid 30070596)
60. Krueger R, Casey M. Focus Groups 3rd ed. Thousand Oaks, CA: Sage Publications; 2000.
61. JO Prochaska WF Velicer JS Rossi 1994 Stages of change and decisional balance for 12 problem behaviors Health Psychol 13 39 46